OECD Home › Science and technology › Biotechnology policies › Latest Documents
This workshop on 11-12 November 2014 in Lausanne, Switzerland will provide an international forum to discuss the challenges and barriers to the development of disease-modifying treatments and diagnostics for Alzheimer’s disease and other dementia.
Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.
This report explores the characteristics of nanotechnology as it relates to technology convergence i.e. actual instances of the convergence of different technology streams in the research and innovation environments within laboratories and companies. It examines four application areas in which nanotechnology plays a strong role (green packaging, food safety and security, pharmaceuticals and medical devices).
Several OECD countries have published their plans for the development of a future bioeconomy, in which bio-based materials and production techniques will contribute significantly to economic and environmental sustainability. The case for support for bio-based chemicals and plastics therefore warrants serious attention.
Synthetic biology is an emerging technology that shows promise for investigating some of the burning issues in biological research. It also has the potential to address some of the grand challenges facing society, such as climate change and energy security.
English, PDF, 566kb
This report presents findings from a pilot survey of business activity in nanotechnology and discusses methodological and practical issues (e.g. the use of definitions) for on-going consideration in work on statistics and indicators for nanotechnology. It identifies how work in this area may support the assessment of other emerging technologies via an integrated framework.
This paper explores the development of the bioplastics sector and its role in national bioeconomy strategies. It finds that bioplastics are at a disadvantage compared to some other biobased products, notably biofuels, that often benefit from preferential treatment. It also notes that greater efforts are needed at the international level as regards standards to avoid creating barriers to international trade in biobased products.
English, PDF, 1,992kb
Governments have a fiscal and social responsibility to ensure that limited research and development resources are used wisely and cost-effectively in support of social, economic, and scientific aspirations. Countries that wish to promote the continued responsible development of nanotechnology will, however, need quantitative data on the economic impact of nanotechnology to guide further investment and policy decisions.
This book discusses scientific and technological tools at the centre of a renewed interest in marine biotechnology that is contributing to a new bioeconomy sector in many countries and offering potential new solutions to global challenges.
This report presents the findings of a research project to investigate the drivers and criteria shaping the application of genomic biotechnology to health in different national settings, and the barriers to implementation nationally and internationally. Findings are based on case studies on Finland, Israel, Luxembourg, Mexico, the United Kingdom, China and South Africa.